Neli Traykova pursues complex securities fraud class actions for institutional investors and individual shareholders who seek to recover losses caused by alleged corporate misconduct.
Neli contributed to litigation and a proposed settlement in 2021 for Twitter shareholders who allege the social media company misrepresented its daily user growth in 2015 to inflate its stock price. She also litigates for investors who allege medical drug manufacturer AbbVie engaged in illegal kickbacks and other misconduct to boost sales for its immunosuppressant drug Humira.
While completing her legal studies, Neli worked as an honors legal intern at the SEC where she assisted with enforcement actions. She was also a student attorney with the Entrepreneurship Law Clinic at American University, counseling small businesses on corporate structuring, taxation, financing and growth and succession planning. Neli was a member of the Business Law Review and competed internationally in mediation and negotiation competitions as a member of the Alternative Dispute Resolution Honor Society.
She acquired additional experience as a FOIA government information specialist and a contracts specialist for the U.S. government prior to law school.
J.D., American University Washington College of Law, 2021
B.S., American University, 2016
Washington, D.C. Bar Association
- District of Columbia